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Background: Selenoprotein S (SelS) is an important endoplasmic reticulum and plasma membrane-located
selenoprotein implicated in inflammatory responses and insulin resistance. However, the effects of SelS on
endothelial cells (ECs) have not been reported. In the present study, the role of SelS in oxidative stress and the
underlying mechanism were investigated in human ECs.
Methods: A SelS over-expression plasmid (pc-SelS) and a SelS-siRNA plasmid were transfected into human umbilical
vein endothelial cells (American Type Culture Collection, USA). The cells were divided into four groups: control, SelS
over-expression (transfected with pc-SelS), vector control, and SelS knockdown (transfected with siRNA-SelS). After
treating the cells with H2O2, the effects of oxidative stress and the expression of caveolin-1 (Cav-1) and protein
kinase Cα (PKCα) were investigated.
Results: Following treatment with H2O2, over-expression of SelS significantly increased cell viability and superoxide
dismutase (SOD) activity, and decreased malondialdehyde (MDA) production and Cav-1 gene and protein expression.
However, no effects on PKCα were observed. In contrast, knockdown of SelS significantly decreased cell viability,
SOD activity, and PKCα gene and protein expression, and increased MDA production and Cav-1 gene and
protein expression.
Conclusions: SelS protects ECs from oxidative stress by inhibiting the expression of Cav-1 and PKCα.
Keywords: Endothelial cell dysfunction, Oxidation, Selenoprotein S, Caveolin-1, Protein kinase CαBackground
Atherosclerosis (AS) is a major life-threatening disease
in modern society. However, the exact mechanism of AS
development is not completely understood and effective
therapies are still required [1]. It has been shown that
endothelial cell dysfunction (ECD) not only triggers but
also promotes the development of AS [2]. Moreover,
oxidative stress is considered to be a primary event in
the pathogenesis of ECD and AS. Therefore, many
resources have been directed towards research into
endothelial protection strategies against oxidative injury
in recent years.
Many selenoproteins, including glutathione peroxidase
1 (GPx1), thioredoxin reductases (TRs), selenoprotein W* Correspondence: dujianling63@163.com
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reproduction in any medium, provided the or(SelW) and selenoprotein P (SelP), participate in intra-
cellular redox homeostasis and play antioxidative roles
[3-6]. Tanis, the homolog of Selenoprotein S (SelS), was
first characterized as a transmembrane protein in the
liver of the Israeli sand rat, Psammomys obesus [7]. SelS
expression was later found in a pancreatic β cell line,
endothelial cells (ECs), human adipose tissue and skeletal
muscle tissue [8-10]. The expression of SelS is related
to inflammation and insulin resistance (IR) in liver and
adipose tissue [8,11,12]. High expression of SelS protected
the pancreatic β cell line, Min6, from oxidative damage
induced by H2O2 [8]. Reduced expression of SelS led
to more severe inflammation in a lipopolysaccharide
(LPS)-injured hepatic cancer cell line [12], suggesting
that SelS may provide a link between IR, inflammation
and oxidative stress pathways through its role as an
antioxidant. Although the effect of SelS on oxidative
stress in ECs has not yet been reported, it is welltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of IR, AS and ECD. Therefore, SelS/Tanis is likely to
be an important mechanistic target for the prevention
and therapy of AS-ECD.
Caveolae, a special type of lipid raft, are highly ex-
pressed in endothelial membranes. Caveolin-1 (Cav-1),
the principal marker protein of caveolae, participates
in the pathologic processes of inflammation and IR
[13,14], leading to ECD. The special scaffold structure
of Cav-1 modulates the activity of protein kinase C
(PKC) during oxidative stress, while PKC regulates gap
junctions through Cav-1-containing caveolae. PKC is
recruited into Cav-1-containing lipid rafts in the cell
membrane from the cytoplasm to induce the redistri-
bution of PKC and Cav-1 in lipid rafts, suggesting a
possible interaction between Cav-1 and PKC [15]. SelS
has four potential phosphorylation sites for PKC. SelS is
also similar to Cav-1 in that it is a membrane protein
highly expressed in ECs. To our knowledge, the inter-
action between SelS and Cav-1 in the oxidative stress
pathway of ECs has not been reported previously. In
this study, we investigated whether SelS participates in
the oxidative stress pathway in ECs using a gain/loss of
SelS function strategy combined with analysis of the
expression levels of Cav-1 and PKCα following treatment
with H2O2.
Methods
Construction of the SelS over-expression plasmid, pc-SelS
A SelS gene fragment (579 bp) was amplified from hu-
man adipose tissue by reverse-transcription polymerase
chain reaction (RT-PCR). Specific primers were designed
according to the nucleotide sequence of human SelS
[GeneBank: NM-018445]. The sense primer sequence
was 5′-CCGCTCGAGATGGAACGCCAAGAGGAGTC
TCTG-3′, and the antisense primer sequence was 5′-
CCGGAATTCGCCTCATCCGCCAGATGACGGGCC-3′.
Restriction enzyme sites were introduced into the sense
primer (XhoI at the 5′ end) and antisense primer (EcoRI
at the 3′ end) to enable subcloning of the amplified
fragment. The PCR product was cloned into the
pMD18-T Simple Vector and then digested with XhoI
and EcoRI. The digested SelS DNA fragment was purified
and subcloned into the pcDNA3.1 eukaryotic expression
vector to generate the pcDNA3.1-SelS recombinant
plasmid (pc-SelS). After confirming the DNA sequence,
pc-SelS was transiently transfected into human umbilical
vein endothelial cells (HUVECs) via liposomes.
Construction of the SelS low expression plasmid, siRNA-SelS
Three interfering target sequences and one negative
control (HK) were designed according to the human
SelS gene sequence [GeneBank: NM-018445] using online
software provided by Wuhan Jing Contest Company andsynthesized into double-strand DNA templates. The







After cloning into the pcDNA3.1 eukaryotic expression
vector and sequencing, the correct clones were trans-
formed into E. coli DH5α. Kanamycin-resistant clones
were expanded and three interfering plasmids for siRNA-
SelS were sequenced before transfection into HUVECs.
The conditions for plasmid transfection were initially
optimized. Briefly, HUVECs were seeded in six-well plates
and cultured in minimum essential medium supplemented
with 10% fetal bovine serum (Invitrogen Corp, USA) for
24 hours. When the cells had reached approximately
90% confluence, transfection was performed in serum-free
medium using Lipofectamine 2000 (Invitrogen Corp), with
different ratios of plasmid to Lipofectamine. According
to the transfection efficiency under a fluorescence micro-
scope, a 1:1.5 ratio of plasmid (μg) to liposome (μl) was
selected for the experiments.
The interfering effects of three siRNA-SelS plasmids
on gene expression were investigated. Briefly, 4 hours
after transfection, cells were transferred into normal
medium for 24 hours before being harvested. Gene
expression was analyzed by RT-PCR. Finally, one siRNA-
SelS plasmid was chosen for the following experiments
according to its interfering effects (Figure 1).
Expression of pc-SelS and siRNA-SelS in HUVECs
HUVECs were divided into the following four groups:
normal control group, vector control group, pc-SelS group
(SelS over-expression group transfected with pc-SelS), and
siRNA-SelS group (SelS low expression group transfected
with siRNA-SelS). The cells were harvested 24 hours
after transfection. Gene expression was analyzed using
real-time PCR and protein expression was analyzed by
western blotting with a rabbit anti-human SelS polyclonal
antibody (prepared by Wuhan Jing Contest Company,
China).
Effects of SelS on H2O2-injured HUVECs
Analysis of cell viability using the MTT assay
HUVECs were divided into the four groups described
above (normal control group, vector control group, pc-
SelS group, siRNA-SelS group). Twenty-four hours
after transfection, all groups were treated with different
concentrations of H2O2 (0, 400, 600, 800 or 1000 μmol/L)
for 2 hours, and the HUVECs were then washed to
remove the H2O2 prior to addition of 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT).
Figure 1 RT-PCR analysis of SelS gene expression after transfection of siRNA-SelS into HUVEC cells. A. RT-PCR analysis of SelS mRNA in cell
lysates. B. The level of SelS mRNA expression presented as a ratio to GAPDH following densitometric analysis of the RT-PCR products. M: marker;
Con: control group; SelS1, SelS2, SelS3: siRNA-SelS1, 2 and 3 plasmids, respectively. *P < 0.01 compared with the control group.
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at 37°C for 4 hours. The solution was then removed
and the formazan salts were dissolved with dimethyl
sulphoxide, and the absorbance at 570 nm of the resulting
solution was measured.
Determination of MDA production and superoxide
dismutase (SOD) activity
The MDA level and SOD activity were analyzed using
specific reagents according to the protocols provided
by the manufacturer (Nanjing Jiancheng Bioengineering
Institute, China). Briefly, thiobarbituric acid was used
as substrate for the detection of MDA, and the xanthine
oxidase method was used for the detection of SOD
activity.
Real-time PCR
After treatment with 800 μmol/L H2O2 for 24 hours,
the cells in all groups were harvested and total RNAs
were extracted using Trizol reagent (Invitrogen, USA).
The levels of the mRNAs for Cav-1 and PKCα were
examined by real-time PCR analysis. The sequences of the
specific primers for Cav-1 and PKCα used for real-time
PCR were as follows. Cav-1: sense primer, 5′-AACCTC
CTCACAGTTTTCATCCA-3′, antisense primer, 5′-GTC
GTACACTTGCTTCTCGCTCA-3′; PKCα: sense primer,
5′-CCTTCAGACAAAGACCGACGACT-3′, antisense
primer, 5′-CTTCATCAGCTCCGAAACTCCAA-3′; GA
PDH: sense primer, 5′-CGACACCCACTCCTCCACCT
TTG-3′, antisense primer, 5′-TCCACCACCCTGTTGC
TGTAGCC-3′. The SYBR Green PCR Master Mix kit
(Takara Biotechnology Co. Ltd.) was used according to
the manufacturer’s protocol. The real-time PCR reactions
were performed using an Applied Biosystems 7500
Real-time PCR System (Life Technologies, USA). The
PCR mix was first denatured at 95°C for 10 seconds,
followed by 40 cycles of 95°C for 5 s, 59°C for 10 seconds
and 72°C for 10 seconds. The data presented are from
three independent experiments.Western blotting
After treatment with 800 μmol/L H2O2 for 24 hours,
the cells in all groups were harvested and lysed for the
extraction of total proteins. The protein content was
determined using the Bradford assay. Briefly, 30 μg protein
samples were separated on sodium dodecyl sulfate
polyacrylamide gels and transferred to polyvinylidene
difluoride membranes (Millipore). A rabbit anti-human
Cav-1 antibody (1:750, Santa Cruz, USA), a horseradish
peroxidase (HRP)-labeled goat anti-rabbit secondary
antibody (1:6000, Santa Cruz, USA), a mouse anti-human
PKC antibody (1:200, Santa Cruz, USA) and a HRP-
labeled goat anti-mouse secondary antibody (1:2000,
Santa Cruz, USA) were used separately. The signals
were detected using an enhanced chemiluminescence
method (Hybond ECL, Amersham Bioscience, USA). The
protein bands were recorded and analyzed using vision-
worksLS software (UVP Inc., USA). The expression
levels of Cav-1 and PKCα protein were expressed as the
density ratio divided by the density of β-actin.Statistical analyses
Data are presented as mean ± S.D. Statistical analyses
were performed using a paired t-test and one-way analysis
of variance followed by the LSD method with SPSS
version 14.0 software. P values of <0.05 were considered
to be statistically significant.Results
Construction of the SelS over-expression and
interference plasmids
Construction of the SelS over-expression plasmid, pc-SelS
The amplified SelS cDNA sequence was identical to
the sequence in Genebank (NM-018445). The eukar-
yotic expression plasmid, pc-SelS, was further veri-
fied by restriction endonuclease digestion and DNA
sequencing.
Figure 2 Analysis of SelS expression in transfected HUVECs.
A. Level of SelS mRNA expression presented as a ratio to GAPDH
following real-time PCR analysis. B. Level of SelS protein expression
presented as a ratio to β-actin following densitometric analysis of
western blots. C. Western blot analysis of SelS. 1, 2, 3, 4: control group,
pc-SelS group, vector control group and siRNA-SelS group, respectively.
*P < 0.01 compared with control group.
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The three siRNA-SelS plasmids were verified by sequen-
cing. A plasmid to liposome ratio of 1:1.5 was chosen
for liposome transfection.
Gene expression analysis showed that the expression
of SelS was significantly inhibited in all three siRNA-
SelS transfection groups (P < 0.01), and siRNA-SelS1
was selected for the following experiment.
Expression of siRNA-SelS and pc-SelS in HUVECs
Real-time PCR analysis showed that SelS gene expression
in both the pc-SelS over-expression group (82.51 ± 0.42,
P < 0.01 versus vector control group) and the siRNA-SelS
low expression group (2.67 ± 0.16, P < 0.01 versus vector
control group) was significantly different from the vector
control group (26.54 ± 0.35). Additionally, expression of
the SelS mRNA in the low expression group was knocked
down by approximately 90% (Figure 2A and B).
Western blot analysis showed similar results, and the
expression of SelS protein in the siRNA-SelS group was
decreased by approximately 30% (Figure 2C).
Effects of SelS on H2O2-induced EC injury
Effects of SelS on cell viability
All groups of HUVECs showed decreased cell viability after
exposure to different concentrations of H2O2 for 6 hours.
Cell viability in the siRNA-SelS group was significantly
lower than that in the other groups (P < 0.01), while cell
viability in the SelS over-expression group was significantly
higher than that in the other groups (P < 0.01) following
stimulation with H2O2 at concentrations of 800 and
1000 μmol/L (Figure 3A).
Effects of SelS on MDA production
The MDA content in the cell medium increased when the
concentration of H2O2 was increased. The MDA content in
the siRNA-SelS group was significantly higher than that in
the SelS over-expression group, the normal control group
and the vector transfection group (treated with H2O2 at
concentrations of 600, 800 and 1000 μmol/L, respectively).
The MDA content in the SelS over-expression group was
significantly lower than in the other groups at these three
concentrations of H2O2 (Figure 3B).
Effects of SelS on SOD activity
SOD activity in the siRNA-SelS group was signifi-
cantly decreased, while SOD activity in the SelS over-
expression group was significantly increased, by H2O2
treatment compared with the other groups (P < 0.01)
(Figure 3C).
Effects of SelS on Cav-1 expression
Cav-1 gene and protein expression were significantly
increased by treatment with 800 μmol/L H2O2 comparedwith the corresponding control groups not treated with
H2O2 (P < 0.01). The levels of Cav-1 gene and protein were
significantly decreased in the SelS over-expression group,
and significantly increased in the siRNA-SelS group, when
compared with the vector control groups after H2O2
treatment (P < 0.01) (Figure 4).Effects of SelS on PKCα expression
PKCα gene and protein expression were significantly
increased in the siRNA-SelS group treated with
800 μmol/L H2O2 compared with the corresponding
groups treated with or without H2O2 (P < 0.01). No
significant changes were observed in the other groups
(P > 0.05) (Figure 5).
Figure 3 Effects of SelS on H2O2-induced EC injury. A. Effects of SelS on cell viability. B. Effects of SelS on MDA production. C. Effects of SelS
on SOD activity. The black, dark grey, grey and white columns indicate the control group, pc-SelS group, vector control group and siRNA-SelS
group, respectively. *P < 0.05, #P < 0.01 compared with vector control group. n = 3.
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The novel selenoprotein, Tanis, was first identified in P.
obesus, an animal model of type 2 diabetes and the meta-
bolic syndrome. SelS, the human homolog of Tanis, was
later found to be expressed in a variety of tissues as an
important endoplasmic reticulum (ER) and plasma mem-
brane-located selenoprotein.
SelS has been reported to have multiple biological activ-
ities. SelS promoted the reverse translocation of unfolded
and misfolded proteins to the cytoplasm from the ER
space for degradation after ubiquitination to maintain ER
homeostasis [16]. Moreover, the SelS gene locates within a
region of chromosome 15q26.3, which also contains many
inflammation-related loci. It was shown that proinflamma-
tory cytokines activated the transcription of SelS, and up-
regulation of SelS inhibited the production of cytokines
through a feedback loop [7,17]. SelS also protected Min6
islet cells from oxidative stress-induced toxicity [4]. How-
ever, the role of SelS in ECs has not yet been reported.
Therefore, in the present study, the antioxidative effects of
SelS in ECs were investigated using a gain/loss of function
approach.
The results of the present study demonstrated that
increased expression of SelS protected HUVECs from H2O2
damage by inducing increased cell viability and SOD activity,
and decreased MDA production. Interfering with the SelS
gene significantly decreased the antioxidative activity of
HUVECs treated with H2O2, as shown by decreased cell via-
bility and SOD activity, and increased MDA production.
Our results are consistent with those of Zeng et al., whoreported that interfering with SelS gene expression exacer-
bated LPS-induced inflammation injury in a liver cancer cell
line [8]. Moreover, the present study demonstrated that
expression of Cav-1 in ECs was increased by stimulation
with H2O2, while the increase in Cav-1 in the SelS over-
expression group was significantly lower than that in the
SelS low expression group. These results suggest that the
protective effect of SelS in response to H2O2-induced
damage is related to the down-regulation of Cav-1.
Cav-1, the key structural protein in caveolae, is highly
expressed in ECs. However, only a few studies on Cav-1 and
ECs have been reported. In diabetic rats, oxidative stress in
ECs increased the production of VEGF and then induced
the gathering of caveolae and increased expression of Cav-1,
leading to capillary hyperpermeability to plasma macromol-
ecules and the intensification of membrane-cytoplasm trans-
portation [18]. Later, the role of Cav-1 in the mechanism of
oxidant-induced pulmonary vascular hyperpermeability and
edema formation was investigated using a Cav-1(-/-) mouse.
This study showed that H2O2 exposure induced the phos-
phorylation of Cav-1, which resulted in endothelial barrier
disruption [19]. Further research also confirmed the induc-
tion of Cav-1 following oxidative stress and the fundamental
role of Cav-1 in endothelial barrier function [20]. It also has
been shown that caveolae and Cav-1 may play an important
role in the mediation of native and modified LDL uptake/
efflux and transcytotic trafficking in ECs [21]. These findings
suggest a pro-atherogenic role of Cav-1 and caveolae. Our
present study has shown that SelS may down-regulate
Cav-1 expression to protect ECs from oxidative stress,
Figure 4 Effects of SelS on the expression of Cav-1 in ECs
stimulated with or without H2O2. A. The level of Cav-1 gene
expression presented as a ratio to GAPDH following real-time PCR
analysis. B. The level of Cav-1 protein expression presented as a ratio
to β-actin following densitometric analysis of western blots. C. Western
blot analysis of Cav-1 expression in HUVECs not stimulated with H2O2.
D. Western blot analysis of Cav-1 expression in HUVECs stimulated with
800 μmol/L H2O2. White column: no H2O2 stimulation; shaded column:
stimulation with 800 μmol/L H2O2. 1, 2, 3, 4: control group, pc-SelS
group, vector control group and siRNA-SelS group, respectively.
#P < 0.01 compared with the corresponding control groups not
stimulated with H2O2; *P < 0.01 compared with the vector control
group; $P < 0.01 compared with the SelS over-expression
group. n = 3.
Figure 5 Effects of SelS on the expression of PKCα in ECs
stimulated with or without H2O2. A. The level of PKCα gene
expression presented as a ratio to GAPDH following real-time PCR
analysis. B. The level of PKCα protein expression presented as a ratio
to β-actin following densitometric analysis of western blots. C. Western
blot analysis of PKCα expression in HUVECs not stimulated with H2O2.
D. Western blot analysis of PKCα expression in HUVECs stimulated with
800 μmol/L H2O2. White column: no H2O2 stimulation; shaded column:
stimulation with 800 μmol/L H2O2. 1, 2, 3, 4: control group, pc-SelS
group, vector control group and siRNA-SelS group, respectively.
*P < 0.01 compared with the vector control group. n = 3.
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pathophysiologic stages of AS.
PKC has been reported to be involved in the mechanism
of antioxidative stress. Numerous findings have revealed
that PKC alpha is a mediator in the activation of stress-
response kinase. Kuo DY et al. demonstrated that PKC
alpha knock-down could reverse the increase of SOD gene
expression induced by phenylpropanolamine [22]. They
revealed that PKC alpha signaling was an upstream medi-
ator that regulates SOD gene expression, and the increase
in SOD induced by PKC alpha can reduce oxidative stress.
Makino J et al. showed that expression of SOD in the
vascular wall was completely blocked by pre-treatment
with GF109203X, an inhibitor of PKC, suggesting a direct
effect of PKC on SOD expression [23]. Some selenium-
containing compounds showed antioxidative effects by
inhibiting PKC via redox-active cysteine residues in the
catalytic domain of PKC [24,25]. Rayudu G and his team
have shown that oxidative stress can stimulate PKC activity,
and the interaction of seleno-compounds with the redox-
active cysteine-rich regions in PKC is important for their
antioxidative function [25]. The present study showed that
the expression levels of PKCα gene and protein were
significantly increased in the SelS low expression group, but
there was no significant change in the SelS over-expression
group. Therefore, SelS may have an inhibitory effect on
PKCα under normal conditions, while the decreased
expression of SelS relieved the inhibition on PKCα leading
to increased PKCα expression and oxidative injury. How-
ever, high expression of SelS showed no significant effect
on the expression of PKCα, suggesting that other mecha-
nisms may be involved. Also, whether other subtypes of
PKC (PKCβ, PKCγ) play roles in the SelS pathway should
be investigated further.
Conclusions
Our study showed that up-regulation of SelS inhibited
H2O2-induced Cav-1 expression, and down-regulation of
SelS increased the expression of Cav-1 and PKCα. There-
fore, our study demonstrated, for the first time, the protect-
ive effect of SelS on oxidation-injured ECs. Furthermore,
our results suggest that SelS may inhibit expression of
Cav-1 to inhibit PKCα and block downstream activation of
the PKC signaling pathway, leading to its antioxidative pro-
tection effect in ECs. Further experiments will focus on the
mechanism in more detail. Specific inhibitors of Cav-1 and
PKCα will be used to demonstrate their roles in the SelS
effect when SelS is over-expressed or knocked down. Also,
co-precipitation of Cav-1 and SelS/PKCα will be performed.
Moreover, SelS has been shown to perform complex
biological activities via diverse mechanisms during many
pathological processes, including oxidative stress, ER stress
and cytokine production. Future studies will also focus on
the link between the effects of SelS on oxidative stress, ERstress and inflammation. The in vivo effects of SelS
transfection and knockdown in mice will also be investi-
gated in order to clarify the role of SelS in the organism,
which may be more meaningful for the prevention and
therapy of AS-ECD.
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